VERU INC. Accounts Receivable, before Allowance for Credit Loss, Noncurrent
VERU INC. (VERU) had Accounts Receivable, before Allowance for Credit Loss, Noncurrent of $0 as of 2020-09-30, per its 10-K filed 2020-12-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent › Accounts Receivable, after Allowance for Credit Loss, Noncurrent
us-gaap:AccountsReceivableGrossNoncurrent · last filed 2020-12-10
- 2020-09-30: Accounts Receivable, before Allowance for Credit Loss, Noncurrent $0.00.
- 2017-09-30: Accounts Receivable, before Allowance for Credit Loss, Noncurrent $7.84M.
- 2017-06-30: Accounts Receivable, before Allowance for Credit Loss, Noncurrent $7.84M.
- 2017-03-31: Accounts Receivable, before Allowance for Credit Loss, Noncurrent $7.84M.
| Period end | Accounts Receivable, before Allowance for Credit Loss, Noncurrent |
|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-12-10 |
| 2017-09-30 | $7.84M 10-K · filed 2018-12-13 |
| 2017-06-30 | $7.84M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $7.84M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $7.84M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $7.84M 10-K · filed 2018-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |